-
1
-
-
67650073366
-
Recent patterns in gastric cancer: a global overview.
-
Bertuccio P, Chatenoud L, Levi F, et al (2009). Recent patterns in gastric cancer: a global overview. Int J Cancer, 125, 666-73.
-
(2009)
Int J Cancer
, vol.125
, pp. 666-673
-
-
Bertuccio, P.1
Chatenoud, L.2
Levi, F.3
-
2
-
-
33846189403
-
Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas.
-
Griffiths EA, Pritchard SA, Valentine HR, et al (2007). Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer, 96, 95-103.
-
(2007)
Br J Cancer
, vol.96
, pp. 95-103
-
-
Griffiths, E.A.1
Pritchard, S.A.2
Valentine, H.R.3
-
3
-
-
0034614637
-
The hallmarks of cancer.
-
Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.
-
(2000)
Cell
, vol.100
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
4
-
-
84880920150
-
Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1alpha) expression in gastric cancer.
-
Isobe T, Aoyagi K, Koufuji K, et al (2013). Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1alpha) expression in gastric cancer. Int J Clin Oncol, 18, 293-304.
-
(2013)
Int J Clin Oncol
, vol.18
, pp. 293-304
-
-
Isobe, T.1
Aoyagi, K.2
Koufuji, K.3
-
5
-
-
79952232216
-
Global cancer statistics.
-
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
-
6
-
-
48149091757
-
Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis
-
Kolev Y, Uetake H, Takagi Y, Sugihara K (2008). Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol, 15, 2336-44.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 2336-2344
-
-
Kolev, Y.1
Uetake, H.2
Takagi, Y.3
Sugihara, K.4
-
7
-
-
84873602673
-
Prognostic value of vascular endothelial growth factor expression in resected gastric cancer.
-
Liu L, Ma XL, Xiao ZL, et al (2012). Prognostic value of vascular endothelial growth factor expression in resected gastric cancer. Asian Pac J Cancer Prev, 13, 3089-97.
-
(2012)
Asian Pac J Cancer Prev
, vol.13
, pp. 3089-3097
-
-
Liu, L.1
Ma, X.L.2
Xiao, Z.L.3
-
8
-
-
77955491646
-
HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy.
-
Nakamura J, Kitajima Y, Kai K, et al (2010). HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy. Int J Cancer, 127, 1158-71.
-
(2010)
Int J Cancer
, vol.127
, pp. 1158-1171
-
-
Nakamura, J.1
Kitajima, Y.2
Kai, K.3
-
9
-
-
44649198327
-
Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.
-
Oh SY, Kwon HC, Kim SH, et al (2008). Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer. BMC Cancer, 8, 123.
-
(2008)
BMC Cancer
, vol.8
, pp. 123
-
-
Oh, S.Y.1
Kwon, H.C.2
Kim, S.H.3
-
10
-
-
78751584845
-
Expressions of hypoxia-inducible factor-1alpha and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features.
-
Qiu MZ, Han B, Luo HY, et al (2011). Expressions of hypoxia-inducible factor-1alpha and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features. Tumour Biol, 32, 159-66.
-
(2011)
Tumour Biol
, vol.32
, pp. 159-166
-
-
Qiu, M.Z.1
Han, B.2
Luo, H.Y.3
-
11
-
-
0142166332
-
Targeting HIF-1 for cancer therapy.
-
Semenza GL (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3, 721-32.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 721-732
-
-
Semenza, G.L.1
-
12
-
-
85008354636
-
Expressions of VEGF, HIF-1 in gastric cancer and their impact on prognosis.
-
Shen CL, Shen ZB, Chen WD (2010). Expressions of VEGF, HIF-1 in gastric cancer and their impact on prognosis. Chin Gen Prac, 13, 2460-6.
-
(2010)
Chin Gen Prac
, vol.13
, pp. 2460-2466
-
-
Shen, C.L.1
Shen, Z.B.2
Chen, W.D.3
-
13
-
-
2942685341
-
Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.
-
Stoeltzing O, McCarty MF, Wey JS, et al (2004). Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst, 96, 946-56.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 946-956
-
-
Stoeltzing, O.1
McCarty, M.F.2
Wey, J.S.3
-
14
-
-
33749016506
-
Overexpression of hypoxia-inducible factor 1α and p53 is a marker for an unfavorable prognosis in gastric cancer.
-
Sumiyoshi Y, Kakeji Y, Egashira A, et al (2006). Overexpression of hypoxia-inducible factor 1α and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res, 12, 5112-7.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5112-5117
-
-
Sumiyoshi, Y.1
Kakeji, Y.2
Egashira, A.3
-
15
-
-
0142175222
-
Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach.
-
Takahashi R, Tanaka S, Hiyama T, et al (2003). Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep, 10, 797-802.
-
(2003)
Oncol Rep
, vol.10
, pp. 797-802
-
-
Takahashi, R.1
Tanaka, S.2
Hiyama, T.3
-
16
-
-
34547450763
-
Practical methods for incorporating summary time-to-event data into meta-analysis.
-
Tierney JF, Stewart LA, Ghersi D, et al (2007). Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 8, 16.
-
(2007)
Trials
, vol.8
, pp. 16
-
-
Tierney, J.F.1
Stewart, L.A.2
Ghersi, D.3
-
17
-
-
33645241816
-
Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma.
-
Urano N, Fujiwara Y, Doki Y, et al (2006). Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. Gastric Cancer, 9, 44-9.
-
(2006)
Gastric Cancer
, vol.9
, pp. 44-49
-
-
Urano, N.1
Fujiwara, Y.2
Doki, Y.3
-
18
-
-
0030512898
-
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation
-
Vermeulen PB, Gasparini G, Fox SB, et al (1996). Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer, 32A, 2474-84.
-
(1996)
Eur J Cancer
, vol.32 A
, pp. 2474-2484
-
-
Vermeulen, P.B.1
Gasparini, G.2
Fox, S.B.3
-
19
-
-
85008382511
-
Expression and clinical significance of Notch1 and HIF-1α proteins in human gastric carcinoma.
-
Yang ZR, Wu Q, Li DW, Chen JW (2007). Expression and clinical significance of Notch1 and HIF-1α proteins in human gastric carcinoma. J Shanxi Med Univ, 38, 498-502.
-
(2007)
J Shanxi Med Univ
, vol.38
, pp. 498-502
-
-
Yang, Z.R.1
Wu, Q.2
Li, D.W.3
Chen, J.W.4
-
20
-
-
0037414180
-
YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.
-
Yeo EJ, Chun YS, Cho YS, et al (2003). YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst, 95, 516-25.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 516-525
-
-
Yeo, E.J.1
Chun, Y.S.2
Cho, Y.S.3
-
21
-
-
0033571682
-
Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.
-
Zhong H, De Marzo AM, Laughner E, et al (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res, 59, 5830-5.
-
(1999)
Cancer Res
, vol.59
, pp. 5830-5835
-
-
Zhong, H.1
De Marzo, A.M.2
Laughner, E.3
-
22
-
-
77953460145
-
Expressions of TP and HIF-1α in gastric carcinoma tissues and their correlations with prognosis.
-
G L
-
Zhou LH, Li LH, G L (2009). Expressions of TP and HIF-1α in gastric carcinoma tissues and their correlations with prognosis. Chin J Cance R Prev Treat, 16, 1315-9.
-
(2009)
Chin J Cance R Prev Treat
, vol.16
, pp. 1315-1319
-
-
Zhou, L.H.1
Li, L.H.2
|